Rephonic
Artwork for Research To Practice

Research To Practice | Oncology Videos

Dr Neil Love
Immunotherapy
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Clinical Trials
Multiple Myeloma
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
Antibody-Drug Conjugates
Chemotherapy
PARP Inhibitors
ESR1 Mutations
Er-Positive Breast Cancer
Breast Cancer
Pembrolizumab
Endometrial Cancer
Non-Hodgkin Lymphoma
HER2
Small Cell Lung Cancer
Acute Myeloid Leukemia

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

PublishesDailyEpisodes1524Founded13 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Research To Practice

Latest Episodes

Featuring perspectives from Dr David H Ilson and Dr Kohei Shitara, including the following topics:

• Introduction (0:00)

• Biomarker Evaluation in Localized and Metastatic Disease (1:49)

• Role of Immune Checkpoint Inhibitors in the Management o... more

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gastroesophageal Cancers | Faculty Presentation 1: Role of Immune Checkpoint Inhibitors in the Management of Gastroesophageal Cancers — David H Ilson... more

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Gastroesophageal Cancers | Faculty Presentation 2: Other Available Therapeutic Approaches — Kohei Shitara, MD

CME information and select publicati... more

Featuring perspectives from Dr Rahul Aggarwal, Dr Matthew D Galsky and Dr Tian Zhang, including the following topics:

• Introduction: Welcome GU Oncology Fellows! (0:00)

• Prostate Cancer — Dr Aggarwal (12:48)

• Urothelial Bladder Cancer — Dr Ga... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Claire Harrison
Professor at Guys and St. Thomas NHS Foundation Trust, London
Guys and St. Thomas NHS Foundation Trust
Episode: Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting
Raajit K Rampal
Physician-scientist at Memorial Sloan-Kettering Cancer Center, New York
Memorial Sloan-Kettering Cancer Center
Episode: Myelofibrosis — Proceedings from a Webinar Held in Conjunction with the 2026 ASCO Annual Meeting
Reva Basho
Faculty presenter from Los Angeles
Physician
Episode: For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Kelly Fischer
Faculty presenter from Boston
Nurse Practitioner
Episode: For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Melissa Rikal
Faculty presenter from Nashville
Nurse Practitioner
Episode: For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Chiru Agarwal
Clinical investigator discussed in the session
Episode: Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Tisiana Leal
Clinical investigator featured in case presentations
Episode: Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Anne Chiang
Investigator/faculty presenting on ongoing trials and consolidation strategies
Episode: Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Apar Ganti
Investigator discussing IO backbone selection and maintenance sequencing
Episode: Small Cell Lung Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Hosts

Neil Love
Host from Research To Practice; frequently guides discussions and presents consensus updates; associated with multiple program strands including Year in Review and CME-linked content.
Seth Wander
Moderator from Boston introducing and guiding the session.
Misty Shields
Host of Second Opinion CME meeting; coordinates session flow.
Yelena Janjigian
Moderator of the discussion; prominent oncology expert.
John Heymach
Oncologist presenting expert insights; thoracic oncology focus.

Reviews

4.6 out of 5 stars from 153 ratings
  • Valued resource

    Relentless in its focus on the general medical oncolgist. An important resource.

    Apple Podcasts
    5
    a h/o
    United States5 years ago
  • Excellent

    Since my fellowship training Neil Love has made these presentations the best of the best in staying UpToDate with current and future practice

    Apple Podcasts
    5
    obete man
    United States5 years ago
  • RTP is is consistently great

    Research to Practice continues to put out well produced clinically relevant content from expert faculty that is applicable to daily oncology practice. It is an invaluable resource for me.

    Apple Podcasts
    5
    OKMedStudent
    United States6 years ago
  • Gold standard

    I’m not an oncologist but I love listening to all of these podcasts. I have to imagine that Neil Love is an absolute giant in this field. So interesting and informative.

    Apple Podcasts
    5
    Bob a la sob mob
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

- Appreciated even by non-oncologists for its informative discussions.
- Valuable resource for staying current with general medical oncologists.
- Consistently high-quality, clinically relevant content from expert faculty.
- A well-produced source of practical oncology knowledge for daily practice.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#107
Hong Kong/Science
Apple Podcasts
#124
China/Science
Apple Podcasts
#191
Brazil/Science
Apple Podcasts
#206
Ireland/Science

Talking Points

Recent interactions between the hosts and their guests.

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
Q: Where do we stand on the use of Zungurtinib for HER2-mutant NSCLC and how does it compare to Seviburtinib in terms of tolerability and sequencing?
Zungurtinib is highly active and more selective for HER2 mutations with minimal EGFR-related toxicities, making it a preferred monotherapy option in many settings, while Seviburtinib retains activity but carries higher rates of diarrhea and rash; sequencing considerations are evolving as more lines become approved and combination strategies are investigated.
Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR
Q: What is the vision for why newer TKIs show such a big difference in efficacy between fusions and mutations?
The drugs targeting gene fusions can inhibit a constitutively active oncogenic fusion protein with a larger therapeutic window, whereas mutations often involve small changes in the kinase pocket that are harder to selectively inhibit without affecting the wild-type protein, leading to tighter margins and more off-target effects in mutations compared to fusions.
Chronic Lymphocytic Leukemia — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting
Q: When do you consider starting treatment in asymptomatic patients with rising lymphocytosis or nodal burden?
Most speakers emphasized waiting for stable or progressive trends, not isolated spikes, and considering high-risk cytogenetics or rapid bulk growth as triggers for therapy initiation.
Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 2
Q: Question to the faculty, how do Majic trial results and MRD status influence future practice?
Discussion emphasizes the ongoing evolution of MRD as a meaningful endpoint for fixed-duration therapy, its potential as a surrogate for PFS in certain contexts, and the need for more data to determine when MRD status should drive treatment duration decisions.
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Q: In front-line or early settings, should Zanidatumab or other HER2-targeted regimens be preferred given new trial data?
Experts suggest Zanidatumab may offer a favorable profile as an HER2-directed option, potentially changing the standard of care in some settings, but emphasize awaiting FDA decisions and the need to compare arms carefully to established regimens like full Fox-based regimens plus pembrolizumab.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Research To Practice

What is Research To Practice about and what kind of topics does it cover?

This program concentrates on cutting-edge oncology practice, featuring expert clinicians and researchers discussing recent data, pivotal trials, and real-world management strategies across solid tumors and hematologic cancers. Episodes frequently cover new therapies, biomarker-guided treatment, sequencing decisions, and practical toxicity management, often tied to major conferences and pivotal symposiums. A standout element is the breadth of high-profile guest experts and the emphasis on translating trial data into clinical decision-making, including transplant eligibility, maintenance strategies, and emerging targeted therapies. Overall, it's a resource for practitioners seeking up-to-date, clinically actionable insights and nuanced expert... more

Where can I find podcast stats for Research To Practice?

Rephonic provides a wide range of podcast stats for Research To Practice. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Research To Practice and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Research To Practice get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Research To Practice, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Research To Practice?

Rephonic provides comprehensive predictive audience data for Research To Practice, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Research To Practice have?

To see how many followers or subscribers Research To Practice has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Research To Practice?

These podcasts share a similar audience with Research To Practice:

1. Two Onc Docs
2. Oncology Today with Dr Neil Love
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. Breast Cancer Update
5. OncLive® On Air

How many episodes of Research To Practice are there?

Research To Practice launched 13 years ago and published 1524 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Research To Practice?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Research To Practice?

Rephonic pulls ratings and reviews for Research To Practice from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Research To Practice?

Rephonic provides full transcripts for episodes of Research To Practice. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Research To Practice?

Recent guests on Research To Practice include:

1. Claire Harrison
2. Raajit K Rampal
3. Reva Basho
4. Kelly Fischer
5. Melissa Rikal
6. Chiru Agarwal
7. Tisiana Leal
8. Anne Chiang

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days